Ropivacaine peritonsillar infiltration for analgesia after adenotonsillectomy in children: A randomized, double-blind, placebo-controlled Study

Marco Gemma, Lucia Oriella Piccioni, Luigi Gioia, Luigi Beretta, Mario Bussi

Research output: Contribution to journalArticlepeer-review

Abstract

Objectives: Our randomized, double-blind, placebo-controlled study evaluates, the possible benefit of peritonsillar infiltration with 0.75% ropivacaine hydrochloride on the pain level after adanotonsillectomy in 3-to 7-year-old children. Methods: We randomly administered intraoperative peritonsillar infiltration with 0.2 mL/kg ropivacaine 0.75% (group R) or 0.2 mL/kg saline 0.9% (group F) to sixty 3-to 7-year-old children (ASA 1 or 2) who were undergoing adenotonsillectomy. Postoperative pain was assessed 6 and 24 hours after surgery by a 6-face Faces Pain Scale that allowed quantification of pain on a 100-mm horizontal line (0 = no pain). The number of rectal doses of acetaminophen-codeine required during the first postoperative day was recorded. Results: The pain scores did not differ between the groups, either 6 or 24 hours after surgery (group F, 43 ± 26, versus group R, 29 ± 23, and group F, 24 ± 23, versus group R, 30 ± 28, respectively). Acetaminophen-codeine doses were similarly required in the two groups. Conclusions: Peritonsillar infiltration with 0.75% ropivacaine does not provide any major postoperative analgesic effect in 3-to 7-year-old children after adenotonsillectomy. A possible clinically minor analgesia 6 hours after surgery is suggested.

Original languageEnglish
Pages (from-to)227-231
Number of pages5
JournalAnnals of Otology, Rhinology and Laryngology
Volume118
Issue number3
Publication statusPublished - Mar 2009

Keywords

  • Adenotonsillectomy
  • Anesthesia postoperative pain
  • Ropivacaine

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint

Dive into the research topics of 'Ropivacaine peritonsillar infiltration for analgesia after adenotonsillectomy in children: A randomized, double-blind, placebo-controlled Study'. Together they form a unique fingerprint.

Cite this